How many insider declarations has Rasbach Kyle filed?

Rasbach Kyle has filed 1 public insider declaration with SEC (Form 4).

What is Rasbach Kyle's role?

Rasbach Kyle's reported role is not specified by the regulator across the filings.

Which companies does Rasbach Kyle report trades for?

Rasbach Kyle reports trades for Lexeo Therapeutics, Inc..

← Executives ★ Sign in to follow

RK

Rasbach Kyle

CFO

·SEC (Form 4)

Lexeo Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the complete record of transactions filed by Rasbach Kyle. Insider active across 1 company, notably Lexeo Therapeutics, Inc.. In total, 1 filings have been published. History available since 17 January 2025. The latest transaction was disclosed on 17 January 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Rasbach Kyle

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Lexeo Therapeutics, Inc. (US)

申报1 总计

◆

Rasbach Kyle

Chief Financial Officer高管2025年1月17日Lexeo Therapeutics, Inc.

0SEC ↗

40,875 股0Common StockSEC:0001415889-25-001859:0

1 条申报中的 1 条

InsidersTradesSigma

← Executives ★ Sign in to follow

RK

Rasbach Kyle

CFO

·SEC (Form 4)

Lexeo Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the complete record of transactions filed by Rasbach Kyle. Insider active across 1 company, notably Lexeo Therapeutics, Inc.. In total, 1 filings have been published. History available since 17 January 2025. The latest transaction was disclosed on 17 January 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.